BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Healthcare

Nanyang Biologics to Go Public Through Business Combination with RF Acquisition Corp II Valued at 1.5 Billion USD

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform ...

October 03, 2025 | News

Redefining Cancer Care in Southeast Asia: Siemens Healthineers’ Fabrice Leguet on Turning Awareness into Action

Cancer care in Southeast Asia stands at a critical crossroads. While awareness of early detection is high, the translation into meaningful action remains p...

October 01, 2025 | Interaction | By arcilla.fran@biopharmaapac.com

Japan Grants Orphan Drug Designation to JR-446 for Sanfilippo Syndrome Type B

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Co., Ltd. announced that the Ministry of Health, Labour and Welfare of Japa...

October 01, 2025 | News

Olympus Launches OLYSENSE™ AI Endoscopy Portfolio in US and Europe

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today ann...

October 01, 2025 | News

Pier 88 Health and Theranica Secure NMPA Approval for Nerivio® REN Wearable in China

Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greate...

September 30, 2025 | News

Lupin To Acquire VISUfarma To Expand European Specialty Ophthalmology Presence

Global pharma major Lupin Limited announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acqui...

September 30, 2025 | News

Lumonus Partners With Smarter Radiation Oncology® to Expand AI-Driven, Standardised Cancer Care Worldwide

Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Onc...

September 30, 2025 | News

AbbVie Submits FDA Application for Tavapadon After Positive Phase 3 TEMPO Results in Parkinson’s Disease

Submission supported by data from the Phase 3 TEMPO program that demonstrated symptomatic improvement across the Parkinson's disease spectrum Positive r...

September 29, 2025 | News

COREE Identifies First-Ever Microbiome Biomarkers for Diabetes and Obesity Patients

COREE announced on September 15 that it had, for the first time in the world, identified microbiome biomarkers specific to diabetes and obesity p...

September 29, 2025 | News

ASCP Launches Performance and Diagnostics Insights to Elevate Laboratory Benchmarking and Patient Care

- The American Society for Clinical Pathology (ASCP) has launched Performance and Diagnostics Insights (PDI), a groundbreaking platform designed to transfo...

September 29, 2025 | News

Desert Harvest Launches First Menopause Supplement with Human-Identical Lactoferrin

Desert Harvest, a clinically trusted leader in pelvic and hormonal wellness, announced the launch of the first menopause supplement to feature human-i...

September 29, 2025 | News

Leo Cancer Care and Sumitomo Heavy Industries Partner to Launch Upright Proton Therapy Solution

Leo Cancer Care, a leader in innovative cancer care solutions, and Sumitomo Heavy Industries, a global pioneer in medical technology, have announced a stra...

September 29, 2025 | News

The $100 Billion Question: Can India Lead the Global Diabetes Economy?

India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...

September 24, 2025 | Analysis | By editor@biopharmaapac.com

Merck and Siemens Forge Digital Alliance to Transform Drug Discovery and Manufacturing

Memorandum of Understanding signed to deliver end-to-end digital workflows from drug discovery to manufacturing Combines technology from the Siemens...

September 24, 2025 | News

Stay Connected